Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-05-30

Clinical Trial Update: A Phase I/IIa Study for the Treatment of Uveitis With Iontophoresis [Phase 1, Phase 2]

View source ↗

Summary

A Phase I/IIa trial investigating iontophoresis for the treatment of uveitis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Asociación para Evitar la Ceguera en México | Conditions: Uveitis | Phase 1, Phase 2 | Status: WITHDRAWN